In this study, we found that ALB effectively mitigates liver fibrosis by modulating the CXCL12/CXCR4 axis, thereby inhibiting the expression of profibrotic markers and reducing inflammatory responses. Here, CXCR4 is linked to Hepatic fibrosis.